{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:49:05Z","timestamp":1789382945130,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T00:00:00Z","timestamp":1752969600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012128","name":"Austin Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012128","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.hlc.2025.06.1022","type":"journal-article","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T22:54:17Z","timestamp":1762210457000},"page":"1362-1372","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["CardioHepatology: Exploring the Interplay Between Cirrhosis, Cirrhotic Cardiomyopathy, Coronary Artery Disease, and Liver Transplantation"],"prefix":"10.1016","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7664-2189","authenticated-orcid":false,"given":"Claudia R.","family":"Brick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1120-0380","authenticated-orcid":false,"given":"Benjamin","family":"Cailes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avik","family":"Majumdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Testro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0657-3048","authenticated-orcid":false,"given":"Marie","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8739-676X","authenticated-orcid":false,"given":"Ali","family":"Al-Fiadh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyamani","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4201-0173","authenticated-orcid":false,"given":"Madeleine","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2821-1451","authenticated-orcid":false,"given":"Omar","family":"Farouque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop N.","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2025.06.1022_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ehjqcco\/qcaa009","article-title":"Cardiovascular mortality following liver transplantation: predictors and temporal trends over 30 years","volume":"6","author":"Koshy","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"10.1016\/j.hlc.2025.06.1022_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2020.11.038","article-title":"Sudden cardiac death following liver transplantation: incidence, trends and risk predictors","volume":"327","author":"Koshy","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib3","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/lt.26460","article-title":"Cirrhotic cardiomyopathy: appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes","volume":"28","author":"Spann","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajt.2025.05.022","article-title":"Blunted cardiac reserve as a marker of cirrhotic cardiomyopathy-cardiac outcomes following liver transplantation and comparison to the existing guidelines","author":"Cailes","year":"2025","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hlc.2025.06.1022_bib5","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/lt.26000","article-title":"Cirrhotic cardiomyopathy predicts posttransplant cardiovascular disease: revelations of the new diagnostic criteria","volume":"27","author":"Izzy","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib6","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1172\/JCI102813","article-title":"The cardiac output at rest in Laennec's cirrhosis","volume":"32","author":"Kowalski","year":"1953","journal-title":"J Clin Invest"},{"key":"10.1016\/j.hlc.2025.06.1022_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.49.2.268","article-title":"The cardiac response to exercise in cirrhosis","volume":"49","author":"Wong","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.hlc.2025.06.1022_bib8","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/TP.0000000000003245","article-title":"Inducible left ventricular outflow tract obstruction in patients undergoing liver transplantation: prevalence, predictors, and association with cardiovascular events","volume":"105","author":"Cailes","year":"2021","journal-title":"Transplantation"},{"key":"10.1016\/j.hlc.2025.06.1022_bib9","article-title":"Cirrhotic cardiomyopathy: the interplay between liver and heart","volume":"14","author":"Kalluru","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.hlc.2025.06.1022_bib10","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/MCG.0000000000000323","article-title":"High rate of cardiac abnormalities in a postmortem analysis of patients suffering from liver cirrhosis","volume":"49","author":"Wehmeyer","year":"2015","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib11","first-page":"530","article-title":"Cardiac abnormalities in liver cirrhosis","volume":"151","author":"Lee","year":"1989","journal-title":"West J Med"},{"key":"10.1016\/j.hlc.2025.06.1022_bib12","first-page":"206","article-title":"Cirrhotic cardiomyopathy","volume":"98","author":"Elleuch","year":"2020","journal-title":"Tunis Med"},{"key":"10.1016\/j.hlc.2025.06.1022_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/gut.2006.112177","article-title":"Cardiovascular complications of cirrhosis","volume":"57","author":"M\u00f8ller","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.hlc.2025.06.1022_bib14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2009.12.075","article-title":"Cirrhotic cardiomyopathy","volume":"56","author":"Zardi","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib15","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib16","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ncpgasthep0498","article-title":"Therapy insight: cirrhotic cardiomyopathy","volume":"3","author":"Gaskari","year":"2006","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib17","doi-asserted-by":"crossref","first-page":"388","DOI":"10.14309\/ajg.0000000000000462","article-title":"Impaired cardiac reserve on dobutamine stress echocardiography predicts the development of hepatorenal syndrome","volume":"115","author":"Koshy","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib18","first-page":"G87","article-title":"Membrane physical properties determine cardiac beta-adrenergic receptor function in cirrhotic rats","volume":"267","author":"Ma","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib19","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.3390\/jcm9103332","article-title":"The eye as a non-invasive window to the microcirculation in liver cirrhosis: a prospective pilot study","volume":"9","author":"Gifford","year":"2020","journal-title":"J Clin Med"},{"issue":"Suppl 1","key":"10.1016\/j.hlc.2025.06.1022_bib20","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht310.P5739","article-title":"Coronary microvascular dysfunction in patients with advanced liver cirrhosis: the missing piece of the puzzle for understanding cirrhotic cardiomyopathy?","volume":"34","author":"Famoso","year":"2013","journal-title":"Eur Heart J"},{"issue":"Suppl 1","key":"10.1016\/j.hlc.2025.06.1022_bib21","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/j.jhep.2021.01.002","article-title":"Pathophysiology of decompensated cirrhosis: portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction","volume":"75","author":"Engelmann","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib22","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1002\/hep.23918","article-title":"Bacterial DNA translocation is associated with systemic circulatory abnormalities and intrahepatic endothelial dysfunction in patients with cirrhosis","volume":"52","author":"Bellot","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib23","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jhep.2018.02.007","article-title":"Hepatic and cardiac hemodynamics and systemic inflammation in cirrhosis: it takes three to tango","volume":"68","author":"Coenraad","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib24","article-title":"Cardiomyopathy in cirrhosis: from pathophysiology to clinical care","volume":"6","author":"Liu","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.hlc.2025.06.1022_bib25","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.jacc.2023.02.045","article-title":"Gut microbiome-based management of patients with heart failure: JACC review topic of the week","volume":"81","author":"Mamic","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020654","article-title":"The gut microbiome of heart failure with preserved ejection fraction","volume":"10","author":"Beale","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hlc.2025.06.1022_bib27","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/hep.23585","article-title":"Hypertrophic cardiomyopathy and dysregulation of cardiac energetics in a mouse model of biliary fibrosis","volume":"51","author":"Desai","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/hep.28890","article-title":"Bile acid excess induces cardiomyopathy and metabolic dysfunctions in the heart","volume":"65","author":"Desai","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib29","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000109","article-title":"Elevated bile acids are associated with left ventricular structural changes in biliary atresia","volume":"7","author":"Virk","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.hlc.2025.06.1022_bib30","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib31","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.30040","article-title":"Cirrhotic cardiomyopathy after transplantation: neither the transient nor innocent bystander","volume":"68","author":"Izzy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib32","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jjcc.2023.04.007","article-title":"Cirrhotic cardiomyopathy: predictors of major adverse cardiac events and assessment of reversibility after liver transplant","volume":"82","author":"Ali","year":"2023","journal-title":"J Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib33","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5114\/ceh.2021.108708","article-title":"Prevalence and prognostic value of cirrhotic cardiomyopathy as defined according to the proposed new classification","volume":"7","author":"Cesari","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib34","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.1016\/j.hlc.2024.06.015","article-title":"Impaired cardiac reserve is a novel predictor of major adverse cardiovascular events after liver transplantation","volume":"33","author":"Cailes","year":"2024","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2025.06.1022_bib35","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1093\/ehjci\/jeac235","article-title":"Cardiac involvement in non-cirrhotic portal hypertension: MRI detects myocardial fibrosis and oedema similar to compensated cirrhosis","volume":"24","author":"Isaak","year":"2023","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hlc.2025.06.1022_bib36","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1001\/archinte.1958.00030010405009","article-title":"A study of heart disease in one hundred eight hospitalized patients dying with portal cirrhosis","volume":"102","author":"Lunseth","year":"1958","journal-title":"AMA Arch Intern Med"},{"key":"10.1016\/j.hlc.2025.06.1022_bib37","doi-asserted-by":"crossref","first-page":"179","DOI":"10.14309\/ajg.0000000000002032","article-title":"Cardiac dysfunction in the pathogenesis of hepatorenal syndrome","volume":"118","author":"Cailes","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib38","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/apt.15812","article-title":"Fibrogenesis and inflammation contribute to the pathogenesis of cirrhotic cardiomyopathy","volume":"52","author":"Wiese","year":"2020","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hlc.2025.06.1022_bib39","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/lt.22140","article-title":"Predictors of cardiovascular events after liver transplantation: a role for pretransplant serum troponin levels","volume":"17","author":"Coss","year":"2011","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib40","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1002\/lt.22102","article-title":"Pretransplant serum troponin levels are highly predictive of patient and graft survival following liver transplantation","volume":"16","author":"Watt","year":"2010","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib41","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/hep.30934","article-title":"A prospective study identifying predictive factors of cardiac decompensation after transjugular intrahepatic portosystemic shunt: the Toulouse algorithm","volume":"70","author":"Billey","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1136\/gut.2006.102467","article-title":"Diastolic dysfunction is associated with poor survival in patients with cirrhosis with transjugular intrahepatic portosystemic shunt","volume":"56","author":"Cazzaniga","year":"2007","journal-title":"Gut"},{"key":"10.1016\/j.hlc.2025.06.1022_bib43","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(03)14903-3","article-title":"Hepatorenal syndrome","volume":"362","author":"Gin\u00e8s","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2025.06.1022_bib44","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.20687","article-title":"MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation","volume":"41","author":"Alessandria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib45","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jhep.2012.08.027","article-title":"LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction","volume":"58","author":"Nazar","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib47","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1002\/hep.29104","article-title":"Left ventricular systolic function is associated with sympathetic nervous activity and markers of inflammation in cirrhosis","volume":"65","author":"Yotti","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib48","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2023-001319","article-title":"Management of hepatorenal syndrome and associated outcomes: a systematic reviews","volume":"11","author":"Roozbeh","year":"2024","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib49","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/MEG.0b013e32835d09fe","article-title":"Cardiac and renal effects of a transjugular intrahepatic portosystemic shunt in cirrhosis","volume":"25","author":"Busk","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib50","doi-asserted-by":"crossref","first-page":"3507","DOI":"10.1007\/s00261-024-04446-x","article-title":"Unveiling the impact of cirrhotic cardiomyopathy on portal hemodynamics and survival after transjugular intrahepatic portosystemic shunt: a prospective study","volume":"49","author":"Liu","year":"2024","journal-title":"Abdom Radiol (NY)"},{"key":"10.1016\/j.hlc.2025.06.1022_bib51","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14682","article-title":"Impact of cardiac dysfunction on morbidity and mortality in liver transplant candidates","volume":"36","author":"Mohammadi","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/j.hlc.2025.06.1022_bib52","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5114\/ceh.2021.111001","article-title":"Impact of left ventricular diastolic dysfunction on liver transplantation outcomes based on the latest American Society of Echocardiography\/European Association of Cardiovascular Imaging recommendations","volume":"7","author":"Marella","year":"2021","journal-title":"Clin Exp Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib53","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1111\/ctr.12778","article-title":"Impact and persistence of cirrhotic cardiomyopathy after liver transplantation","volume":"30","author":"Sonny","year":"2016","journal-title":"Clin Transplant"},{"key":"10.1016\/j.hlc.2025.06.1022_bib54","doi-asserted-by":"crossref","first-page":"e299","DOI":"10.1161\/CIR.0000000000001104","article-title":"Emerging evidence on coronary heart disease screening in kidney and liver transplantation candidates: a scientific statement from the American Heart Association: endorsed by the American Society of Transplantation","volume":"146","author":"Cheng","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.06.1022_bib55","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1111\/liv.15851","article-title":"Sodium\u2013glucose linked transporter 2 inhibitors in liver cirrhosis: beyond their antidiabetic use","volume":"44","author":"Siafarikas","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.hlc.2025.06.1022_bib56","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.3390\/jcm12062253","article-title":"The effects of SGLT2 inhibitors on liver cirrhosis patients with refractory ascites: a literature review","volume":"12","author":"Miyamoto","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.hlc.2025.06.1022_bib57","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1136\/gutjnl-2011-301348","article-title":"The window hypothesis: haemodynamic and non-haemodynamic effects of beta-blockers improve survival of patients with cirrhosis during a window in the disease","volume":"61","author":"Krag","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.hlc.2025.06.1022_bib58","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1097\/MEG.0000000000001128","article-title":"Beta-blocker therapy for cirrhotic cardiomyopathy: a randomized-controlled trial","volume":"30","author":"Silvestre","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib59","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2020.03.048","article-title":"Short-term hemodynamic effects of \u03b2-blockers influence survival of patients with decompensated cirrhosis","volume":"73","author":"Alvarado-Tapias","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib60","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MCG.0000000000001219","article-title":"Carvedilol combined with ivabradine improves left ventricular diastolic dysfunction, clinical progression, and survival in cirrhosis","volume":"54","author":"Premkumar","year":"2020","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2024.08.010","article-title":"Long-term continuous terlipressin infusion improves cardiac reserve in patients with decompensated cirrhosis","author":"Terbah","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib62","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1053\/j.ajkd.2021.08.016","article-title":"Terlipressin and the treatment of hepatorenal syndrome: how the CONFIRM trial moves the story forward","volume":"79","author":"Belcher","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.hlc.2025.06.1022_bib63","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jhep.2004.09.008","article-title":"Cardiac alterations in cirrhosis: reversibility after liver transplantation","volume":"42","author":"Torregrosa","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0002-8703(60)90192-7","article-title":"The low incidence of myocardial infarction in patients with portal cirrhosis of the liver: a review of 639 cases of cirrhosis of the liver from 17,731 autopsies","volume":"60","author":"Howell","year":"1960","journal-title":"Am Heart J"},{"key":"10.1016\/j.hlc.2025.06.1022_bib65","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.amjcard.2006.01.089","article-title":"Cardiac hemodynamic and coronary angiographic characteristics of patients being evaluated for liver transplantation","volume":"98","author":"Tiukinhoy-Laing","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib66","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/lt.25012","article-title":"Coronary artery disease in decompensated patients undergoing liver transplantation evaluation","volume":"24","author":"Patel","year":"2018","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib67","doi-asserted-by":"crossref","DOI":"10.1097\/LVT.0000000000000642","article-title":"Abdominal aortic calcification on routine pre-operative computed tomography - a novel cardiovascular risk prediction tool in liver transplant patients","author":"Cailes","year":"2025","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.131895","article-title":"Enhancing pre-transplant cardiac assessment: validation and utility of the CAD-LT score with CCTA in liver transplant candidates","volume":"403","author":"Sampaio Rodrigues","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/lt.26331","article-title":"A meta-analysis and systematic review on the global prevalence, risk factors, and outcomes of coronary artery disease in liver transplantation recipients","volume":"28","author":"Xiao","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib70","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib71","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart","volume":"73","author":"Stahl","year":"2019","journal-title":"JACC"},{"key":"10.1016\/j.hlc.2025.06.1022_bib72","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1148\/radiol.14140933","article-title":"High-risk coronary plaque at coronary CT angiography is associated with nonalcoholic fatty liver disease, independent of coronary plaque and stenosis burden: results from the ROMICAT II trial","volume":"274","author":"Puchner","year":"2015","journal-title":"Radiology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib73","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/hep.25593","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification","volume":"56","author":"Kim","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib74","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.hlc.2025.06.1022_bib75","doi-asserted-by":"crossref","first-page":"3488","DOI":"10.1093\/eurheartj\/ehx531","article-title":"The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: a clinical conundrum","volume":"38","author":"McCarthy","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2025.06.1022_bib76","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 practice guidance by the American Association for the Study of Liver Diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib77","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.06.1022_bib78","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/gutjnl-2019-318237","article-title":"Cirrhosis as new indication for statins","volume":"69","author":"Bosch","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.hlc.2025.06.1022_bib79","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jama.2024.27441","article-title":"Simvastatin and Rifaximin in decompensated cirrhosis: a randomized clinical trial","volume":"333","author":"Pose","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.hlc.2025.06.1022_bib80","first-page":"148","article-title":"Effects of PCSK9 inhibitors on metabolic-associated fatty liver disease: a short review","volume":"18","author":"Jakielska","year":"2023","journal-title":"Prz Gastroenterol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib81","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jamacardio.2020.5341","article-title":"Genetic inhibition of PCSK9 and liver function","volume":"6","author":"Rimbert","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib82","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjcard.2020.01.052","article-title":"Impact of cirrhosis on 90-day outcomes after percutaneous coronary intervention (from a nationwide database)","volume":"125","author":"Lu","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib83","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMoa2108749","article-title":"Dual antiplatelet therapy after PCI in patients at high bleeding risk","volume":"385","author":"Valgimigli","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hlc.2025.06.1022_bib84","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/LVT.0000000000000090","article-title":"Drug-eluting stent use with abbreviated dual antiplatelet therapy after percutaneous coronary intervention for liver transplantation evaluation","volume":"29","author":"Koshy","year":"2023","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0223380","article-title":"Dual antiplatelet therapy in patients with cirrhosis and acute myocardial infarction \u2013 a 13-year nationwide cohort study","volume":"14","author":"Wu","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.hlc.2025.06.1022_bib86","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/apt.14121","article-title":"Patients with cirrhosis who have coronary artery disease treated with cardiac stents have high rates of gastrointestinal bleeding, but no increased mortality","volume":"46","author":"Krill","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.hlc.2025.06.1022_bib87","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1016\/j.amjcard.2014.02.014","article-title":"Transradial cardiac catheterization in liver transplant candidates","volume":"113","author":"Huded","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.hlc.2025.06.1022_bib88","first-page":"360","article-title":"Safety of transradial cardiac catheterization in patients with end-stage liver disease","volume":"83","author":"Jacobs","year":"2014","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.hlc.2025.06.1022_bib89","doi-asserted-by":"crossref","first-page":"191","DOI":"10.14740\/cr357w","article-title":"Eptifibatide and cirrhosis: rethinking GPIIb-IIIa inhibitors for acute coronary syndrome in the setting of liver dysfunction","volume":"5","author":"Weinreich","year":"2014","journal-title":"Cardiol Res"},{"key":"10.1016\/j.hlc.2025.06.1022_bib90","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.xjon.2023.07.001","article-title":"Outcomes of patients with advanced liver disease undergoing cardiac surgery","volume":"16","author":"P\u00e9tursson","year":"2023","journal-title":"JTCVS Open"},{"key":"10.1016\/j.hlc.2025.06.1022_bib91","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/icvts\/ivu438","article-title":"Mortality after cardiac surgery in patients with liver cirrhosis classified by the Child-Pugh score","volume":"20","author":"Jacob","year":"2015","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.hlc.2025.06.1022_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.15451","article-title":"Strategy and outcomes of cardiac surgery in patients with cirrhosis: comprehensive approach with liver transplant program","volume":"38","author":"Shimamura","year":"2024","journal-title":"Clin Transplant"},{"key":"10.1016\/j.hlc.2025.06.1022_bib93","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11886-024-02163-x","article-title":"Coronary intervention outcomes in patients with liver cirrhosis","volume":"27","author":"Ang","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/j.hlc.2025.06.1022_bib94","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.06.1022_bib95","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/hep.31023","article-title":"Pre-liver transplant cardiac catheterization is associated with low rate of myocardial infarction and cardiac mortality","volume":"72","author":"Kutkut","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.hlc.2025.06.1022_bib96","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1600-6143.2012.04293.x","article-title":"Liver transplantation outcome in patients with angiographically proven coronary artery disease: a multi-institutional study","volume":"13","author":"Wray","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hlc.2025.06.1022_bib97","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/TP.0000000000001710","article-title":"Incidence of and risk assessment for adverse cardiovascular outcomes after liver transplantation: a systematic review","volume":"101","author":"Konerman","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.hlc.2025.06.1022_bib98","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.108.847178","article-title":"Perioperative risk predictors of cardiac outcomes in patients undergoing liver transplantation surgery","volume":"120","author":"Safadi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2025.06.1022_bib99","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.atherosclerosis.2022.01.020","article-title":"A prospective natural history study of coronary atherosclerosis following liver transplantation","volume":"344","author":"Koshy","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.hlc.2025.06.1022_bib100","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1034\/j.1600-6143.2002.20902.x","article-title":"Cardiovascular toxicities of immunosuppressive agents","volume":"2","author":"Miller","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.hlc.2025.06.1022_bib101","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1002\/lt.24100","article-title":"Evolution of serum atherogenic risk in liver transplant recipients: role of lipoproteins and metabolic and inflammatory markers","volume":"21","author":"Chhatrala","year":"2015","journal-title":"Liver Transpl"},{"key":"10.1016\/j.hlc.2025.06.1022_bib102","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.1016\/j.transproceed.2018.04.030","article-title":"Evolution of biomarkers of atherogenic risk in liver transplantation recipients","volume":"50","author":"Linhares","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/j.hlc.2025.06.1022_bib103","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1161\/CIRCRESAHA.117.306340","article-title":"Determinants and outcomes of accelerated arteriosclerosis: major impact of circulating antibodies","volume":"117","author":"Loupy","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2025.06.1022_bib104","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1097\/TP.0000000000002704","article-title":"Cardiac allograft vasculopathy: the enduring enemy of cardiac transplantation","volume":"103","author":"Nikolova","year":"2019","journal-title":"Transplantation"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950625015124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950625015124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:53:30Z","timestamp":1773003210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950625015124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":104,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S1443950625015124"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2025.06.1022","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CardioHepatology: Exploring the Interplay Between Cirrhosis, Cirrhotic Cardiomyopathy, Coronary Artery Disease, and Liver Transplantation","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2025.06.1022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ).","name":"copyright","label":"Copyright"}]}}